Growing awareness among young population regarding acne and increasing number of manufacturers developing advance drugs for acne treatment drives the market growth. Global Acne Drugs Market expected to observe a rising CAGR in forthcoming period owing to the increasing skin disorders, unhealthy life ...

04.11.2019

Acne Drugs Market Comprehensive Industry Analysis and Growth Driving Factors

Growing awareness among young population regarding acne and increasing number of manufacturers developing advance drugs for acne treatment drives the market growth.
Global Acne Drugs Market expected to observe a rising CAGR in forthcoming period owing to the increasing skin disorders, unhealthy lifestyle, and emergence of biologics. Acne is a common skin disorder that is prevalent in all age groups, especially in adolescents and premature adults. Acne drugs play an important role to reduce inflammation, speed up skin cell turnover, and control bacterial infection.

Growing awareness among young population regarding acne and increasing number of manufacturers developing advance drugs for acne treatment drives the market growth. However, side effects caused due to high power drugs and the high cost of advanced treatments may restrain overall market growth in the years to come.

Drug organizations are presently discovering fresh treatments including inhibition of melanocortin receptor antagonism, stearoyl CoA desaturase, and anti-IL-1 monoclonal antibodies. The upcoming launch of late-stage pipeline items shows promising future for acne drug market.

The market is categorized on the basis of drug type, remedial class, mode of administration, and geography. Based on drug type, market is divided into OTC drugs, prescription drugs, and others. The prescription drugs segment estimated to lead the acne drugs market with significant market share in the years to come. The reason being, growing awareness regarding acne and treatment options among the populace. Exclusively used prescription drugs are Epiduo, Duac, and Benzaclin. These drugs are easily accessible in the market.

Based on remedial class, market is divided into retinoid, antibiotic, hormonal agent, combination drugs (salicylic acid & azelaic acid), dapsone and others. Retinoid segment led the market in the past years and the trend is expected to continue in future. Combination of salicylic acid and azelaic acid is expected to lead the market in the years to come owing to its high effectiveness. Retinoid-like drugs sector comprise lotions, creams, and gels that are derived from vitamin A and consist tazarotene, tretinoin, and adapalene. Whereas, antibiotics are exclusively used to reduce redness by killing excess skin bacteria.



In terms of mode of administration, market is divided into injectable, topical and oral. Topical mode is predicted to hold larger share of market since it is widely preferred by large populace for treatment of acne. Geographically, market is segmented as North America, Europe, Asia, Pacific and Middle East & Africa. Owing to the rising skin disorders and ease accessibility to anti-acne products, North America is predicted to dominate market in the years to come. The prominent players of acne drugs market include Foamix Pharmaceuticals Ltd., Valeant Pharmaceuticals International, Inc., Nestle (Galderma), Allergan (Actavis), Dow Chemical (DowDuPont), Sun Pharma, and GlaxoSmithKline.




Firma: Million Insights

Kontakt-Informationen:
Ansprechpartner: Tom Clark
Stadt: Felton
Telefon: 14086102300


Diese PresseMitteilung kommt von businesspress24.com
http://m.businesspress24.com

Die URL für diese PresseMitteilung ist:
http://m.businesspress24.com/pressrelease1553581.html


Die PresseMitteilung stellt eine Meinungsäußerung des Erfassers dar. Der Erfasser hat versichert, dass die eingestellte PresseMitteilung der Wahrheit entspricht, dass sie frei von Rechten Dritter ist und zur Veröffentlichung bereitsteht. businesspress24.com macht sich die Inhalte der PresseMitteilungen nicht zu eigen. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht businesspress24.com